HIV and alcohol use disorder: we cannot ignore the elephant in the room.

Roberta Agabio, Lorenzo Leggio

Abstract readComment

In one paragraph

Article in The lancet. HIV, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it

0cells of the map it votes in

2citing papers in PubMed

–field-weighted citation impact

1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

Integrated stepped alcohol treatment for patients with HIV and at-risk alcohol use: a randomized trial.Addiction science & clinical practice · 2020
Trial
Substance use service availability in HIV treatment programs: Data from the global IeDEA consortium, 2014-2015 and 2017.PloS one · 2020
Article

4 · The record

Corrections and comments

Comment on
Integrated stepped alcohol treatment for patients with HIV and alcohol use disorder: a randomised controlled trial.2019

5 · Who and what money

Authors and funding

2 authors.

Roberta AgabioDepartment of Biomedical Sciences, Section of Neuroscience and Clinical Pharmacology, University of Cagliari, Monserrato, Italy. Electronic address: agabio@unica.it.

Lorenzo LeggioSection on Clinical Psychoneuroendocrinology and Neuropsychopharmacology, National Institute on Alcohol Abuse and Alcoholism Division of Intramural Clinical and Basic Research and National Institute on Drug Abuse Intramural Research Program, National Institutes of Health, Bethesda, MD, USA; Medication Development Program, National Institute on Drug Abuse Intramural Research Program, National Institutes of Health, Baltimore, MD, USA; Center for Alcohol and Addiction Studies, Brown University, Providence, RI, USA.

Funding

Clinical Psychoneuroendocrinology and Neuropsychopharmacology (CPN)ZIAAA000218 · NIAAA · NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM · PI LEGGIO, LORENZO · 2013 to 2020

$22.8M

Intramural NIH HHS Z99 DA999999Intramural NIH HHS ZIA AA000218

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

AlcoholismHIV InfectionsHumans

Identifiers

PMID31109914

DOI10.1016/S2352-3018(19)30074-8

PMCPMC9298954

What OpenQuestion holds

Textmetadata

LicenceTDM

Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.